Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Testosterone boosts fluid and electrolyte secretion in seminal vesicles, aiding sperm function.

The new chitosan dressing heals wounds better and faster than current products.

2′‐Fucosyllactose reduces hair loss and promotes hair growth in mice.

Cyclosporine may cause hair loss, so patients need monitoring.

Improved hair loss treatment using special particles and surfactants.

Corni Fructus extract may help manage benign prostatic hyperplasia by reducing prostate cell growth and inflammation.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

4D polycarbonate scaffolds show promise for soft tissue repair due to their biocompatibility, shape memory, and minimal immune response.

A new compound was effective for imaging prostate cancer in rats.

A new topical finasteride formulation effectively promotes hair growth with fewer side effects.

Botanical lotion CG428 may help regrow hair and reduce scalp inflammation in chemotherapy patients.

CaM7 and CNGC14 interaction controls root hair growth in Arabidopsis.

Ciprofloxacin is slightly more effective than Clindamycin for reducing acne.

Dermatoscopy can help diagnose CCCA without visible hair loss, offering a less invasive option than biopsy.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Fgf20 is crucial for hair follicle formation by influencing cell movement and growth.

AtCSLD3 and GhCSLD3 genes enhance root growth and cell elongation in plants.

The compound 4c showed strong potential as an anticancer agent.

Early diagnosis and treatment are crucial for managing Berardinelli–Seip syndrome.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.